Cytosorbents Cor (CTSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -1,440 | -7,670 | -6,850 | -6,200 |
| Depreciation Amortization | 40 | 1,250 | 1,190 | 1,120 |
| Other Working Capital | 290 | 60 | 0 | 800 |
| Other Operating Activity | 460 | 3,520 | 3,460 | 3,410 |
| Operating Cash Flow | $-650 | $-2,840 | $-2,200 | $-870 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -20 | 0 | 0 | 0 |
| Other Investing Activity | -10 | -60 | -9 | -3 |
| Investing Cash Flow | $-30 | $-60 | $-9 | $-3 |
| Cash Flows From Financing Activities | ||||
| Other Financing Activity | 0 | 5,080 | 5,080 | 5,030 |
| Financing Cash Flow | $0 | $5,080 | $5,080 | $5,030 |
| Beginning Cash Position | 2,870 | 700 | 700 | 700 |
| End Cash Position | 2,190 | 2,870 | 3,570 | 4,850 |
| Net Cash Flow | $-680 | $2,160 | $2,870 | $4,150 |
| Free Cash Flow | ||||
| Operating Cash Flow | -650 | -2,840 | -2,200 | -870 |
| Free Cash Flow | -650 | -2,840 | -2,200 | -870 |